Back

Carbohydrate antigen 125 as a biomarker for patients with acute heart failure in a nurse-based heart failure unit in a university hospital

12 May 2024 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - diagnostic methods 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Cindy Restrepo

Fundacion Santa Fe de Bogota, Bogota (Colombia)

6 More presentations in this session

Presentation thumbnail
NT-proBNP at day 4 of hospitalization: a single prognostic marker for prediction of both in-hospital and post-discharge outcomes in acute heart failure with reduced ejection fraction
Doctor H. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
High circulating dipeptidyl peptidase 3 is associated with cardiovascular disorders in women with postpartum haemorrhage
Miss N. Assad (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Predicting hospitalizations through post-discharge heart failure appointment: evaluating the FENNIX score's performance
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of proteinuria in patients with acute heart failure
Doctor Y. Akama (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Venous excess ultrasound (VExUS) congestion score in acute heart failure: exploring dynamic changes pre and post diuretic treatment and its correlation with prognosis, insights into potential pitfalls
Doctor F. Turrini (Carpi (MO), IT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - diagnostic methods 2

The Event

Event poster

Heart Failure 2024

12 May 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Beyond NT-proBNP: Ca-125's distinctive role in heart failure - insights into right ventricular predominance and tricuspid regurgitation
thumbnail
Congress Presentation
Utility of CA-125 in evaluating congestion at hospital admission in patients with acute heart failure
thumbnail
Congress Presentation
The role of CA125 as a congestion biomarker in ischemic heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources